โšก In Crisis? Call or Text 988for the National Suicide & Crisis Lifeline โ€” Available 24/7 ยท Free & Confidential
๐Ÿ”ฌ Evidence-Based Clinical Resource

Opioid Receptor Blockade Therapy: Naltrexone and Vivitrol

How extended-release injectable naltrexone blocks the effects of opioids and reduces alcohol cravings.

Key Takeaways & Summary

  • Naltrexone is a non-addictive, non-narcotic opioid antagonist.
  • Vivitrol is a once-monthly extended-release injection.
  • Requires complete detoxification from all opioids (7-14 days) before starting.

The Antagonist Blockade

Naltrexone is a full opioid antagonist. It binds to the mu-opioid receptors with high affinity but does not activate them at all. Instead, it forms a physical blockade. If a person takes opioids while on naltrexone, the opioid molecules cannot bind to the receptors, resulting in absolutely no euphoric or analgesic effects.

Efficacy in Alcohol Use Disorder

Naltrexone is also highly effective for alcohol use disorder. It blocks the endorphin receptors that trigger the pleasurable sensations of drinking, thereby reducing cravings and helping patients maintain abstinence.

Scientific References

  1. Journal of the American Medical Association (JAMA) - Extended-Release Naltrexone Review (2022)

MAT & Detox Admissions

Get details about drug treatment clinics offering Suboxone, Methadone, or Vivitrol near you. Fair Quote available.

๐Ÿ“ž Call Admissions: 888-902-3657